Maria Alejandra Fonseca-Mora
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Maria Alejandra Fonseca-Mora has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Alejandra De-La-Torre
Universidad del Rosario
2 shared publications - Juliana Reyes-Guanes
Escuela Barraquer Research Group, Escuela Superior de Oftalmología del Instituto Barraquer de América, Bogotá, Colombia
2 shared publications - William Rojas-Carabali
Tan Tock Seng Hospital
2 shared publications - Carlos Cifuentes-González
National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore, Singapore
1 shared publication - Germán Mejía-Salgado
Facultad de Ciencias de la Salud, Universidad Autónoma de Bucaramanga - UNAB, Bucaramanga, Colombia
1 shared publication - Miguel Cuevas
Universidad de Antioquía
1 shared publication
Latest Publications
- Open Access
- 1 March 2022
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 116, 27-33
Colombian Ocular Infectious Epidemiology Study (COIES): Herpes Zoster Ophthalmicus prevalence and sociodemographic characterization, 2015-2019
- 1 March 2022
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 116, 27-33
Open AccessColombian Ocular Infectious Epidemiology Study (COIES): Herpes Zoster Ophthalmicus prevalence and sociodemographic characterization, 2015-2019
- Open Access
- 31 December 2021
- Published by Bentham Science Publishers Ltd. in The Open Ophthalmology Journal
- Vol. 15 (1) , 318-321
Necrotizing Anterior Scleritis in a Woman with Terrien's Margin Degeneration: A Case Report
Purpose: The aim of the study was to report the first case of a patient with Terrien's Marginal Degeneration (TMD) who developed necrotizing anterior scleritis without systemic disease association, requiring systemic immunosuppressive treatment. Case Report: A 32-year-old female consulted for bilateral ocular burning and hyperemia. Initially, she was diagnosed with conjunctivitis and treated with topical antibiotics and corticosteroids, with mild transitory improvement but the progression of the disease. Years later, she attended the immunology consultation for a second opinion where TMD with ocular inflammatory component OU was diagnosed. Seven months later, she presented with severe pain, decreased visual acuity, and photophobia in OS. At the slit-lamp examination, necrotizing anterior scleritis with a high risk of perforation in OS was observed. The patient was referred to the rheumatologist and started treatment with systemic corticosteroids and cyclophosphamide, exhibiting a clinical improvement. The patient did not meet the criteria for any systemic illness associated with scleritis, such as autoimmune diseases or vasculitis. Thus, scleritis was related to the adjacent inflammatory process associated with TMD, as an atypical presentation of this disease. Conclusion: Although an inflammatory type of TMD has been proposed, it is essential to follow up closely these patients and consider necrotizing anterior scleritis, a severe ocular disease that requires prompt immunosuppressive management, as a possible atypical associated presentation of this disease.
- 31 December 2021
- Published by Bentham Science Publishers Ltd. in The Open Ophthalmology Journal
- Vol. 15 (1) , 318-321
Open AccessNecrotizing Anterior Scleritis in a Woman with Terrien's Margin Degeneration: A Case Report
Purpose: The aim of the study was to report the first case of a patient with Terrien's Marginal Degeneration (TMD) who developed necrotizing anterior scleritis without systemic disease association, requiring systemic immunosuppressive treatment. Case Report: A 32-year-old female consulted for bilateral ocular burning and hyperemia. Initially, she was diagnosed with conjunctivitis and treated with topical antibiotics and corticosteroids, with mild transitory improvement but the progression of the disease. Years later, she attended the immunology consultation for a second opinion where TMD with ocular inflammatory component OU was diagnosed. Seven months later, she presented with severe pain, decreased visual acuity, and photophobia in OS. At the slit-lamp examination, necrotizing anterior scleritis with a high risk of perforation in OS was observed. The patient was referred to the rheumatologist and started treatment with systemic corticosteroids and cyclophosphamide, exhibiting a clinical improvement. The patient did not meet the criteria for any systemic illness associated with scleritis, such as autoimmune diseases or vasculitis. Thus, scleritis was related to the adjacent inflammatory process associated with TMD, as an atypical presentation of this disease. Conclusion: Although an inflammatory type of TMD has been proposed, it is essential to follow up closely these patients and consider necrotizing anterior scleritis, a severe ocular disease that requires prompt immunosuppressive management, as a possible atypical associated presentation of this disease.